Abrams Royal Pharmacy

FDA Regulatory Profile

Abrams Royal Pharmacy appears in FDA public data with 3 recalls — including 3 Class I (most serious) —, 0 510(k) clearances, 2 FDA inspections, and 1 compliance action on record. Its most recent recall (D-0250-2015, Class I) was initiated on May 31, 2013.

Summary

Total Recalls
3 (3 Class I)
510(k) Clearances
0
Inspections
2
Compliance Actions
1

Recent Recalls

NumberClassProductDate
D-0250-2015Class ICalcium Chloride Preservative Free Sterile injection, 100 mg/ml, 10 ml vial, Rx only, Abrams Royal CMay 31, 2013
D-0252-2015Class ITrace Mineral-5 MDV, supplied in 10 mL vials, Each ML contains: 1 mg Zinc (as sulfate), 0.4 mg CoppeMay 13, 2013
D-0251-2015Class ILidocaine 18.18 mg/mL/Bupivacaine 2.27 mg/mL/Epinephrine 0.0022 mg/mL/Hyaluronidase13.64 u/mL, supplApril 19, 2013